Who is sponsoring NCT03806881?

NCT03806881 is sponsored by Materialise.

What drugs are being tested in NCT03806881?

Interventions in NCT03806881: reversed glenoid prothesis.

What condition does NCT03806881 study?

NCT03806881 studies Arthroplasty, Replacement, Shoulder, Glenoid Cavity, Osteoarthritis of the Shoulder.

Is NCT03806881 still recruiting?

NCT03806881 is currently enrolling by invitation. Last updated 13 March 2024.

Last reviewed 2024-03-13 · How we verify

NCT03806881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant

ENROLLING BY INVITATION Last updated 13 March 2024

What this trial tests

trial testing reversed glenoid prothesis in Arthroplasty, Replacement, Shoulder in 24 participants. Enrolling by invitation.

Timeline

1 July 2019

Primary endpoint
1 October 2024

1 December 2028

Quick facts

Lead sponsor	Materialise
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	24
Start date	1 July 2019
Primary completion	1 October 2024
Estimated completion	1 December 2028
Sites	4 locations across Belgium, Netherlands

Drugs / interventions tested

reversed glenoid prothesis

Conditions studied

Arthroplasty, Replacement, Shoulder — all drugs for Arthroplasty, Replacement, Shoulder →
Glenoid Cavity — all drugs for Glenoid Cavity →
Osteoarthritis of the Shoulder — all drugs for Osteoarthritis of the Shoulder →

Sponsor

Materialise

Who can join

18 and older, any sex, with Arthroplasty, Replacement, Shoulder or Glenoid Cavity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This post-market follow-up study investigates improvement in clinical and radiological outcome after reversed total shoulder arthroplasty with the patient-specific Glenius Glenoid Reconstruction system

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthroplasty, Replacement, Shoulder

Currently open trials in the same condition.

NCT06891378 — At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty · NA · recruiting
NCT06025331 — Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA? · NA · recruiting
NCT04507412 — Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty · Phase 4 · recruiting
NCT05030220 — Testosterone Levels and Cutibacterium · recruiting
NCT04258267 — Which Factors Influence the Outcome After Anatomical and Reverse Shoulder Arthroplasty? · NA · recruiting

Other Materialise trials

Trials by the same sponsor.

NCT02499523 — Monocentric Study on Acetabulum Patient-specific Pin Drilling Guides · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03806881 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Materialise
Last refreshed: 13 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03806881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing